KRISTY SCHRYVER: Open Payments
NPI 1528568490 · CRESTVIEW, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,109 in 48 payments from 13 companies in 2025. Trend: 2023 $1,497 · 2024 $495 · 2025 $1,109
Food & beverage: $1,109
| Company | Payments | Amount |
|---|---|---|
| Madrigal Pharmaceuticals | 6 | $225 |
| ABBVIE INC. | 12 | $202 |
| Gilead Sciences, Inc. | 2 | $153 |
| Ardelyx, Inc. | 6 | $117 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 6 | $114 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $65 |
| Novo Nordisk Inc | 3 | $54 |
| Janssen Biotech, Inc. | 3 | $48 |
| PFIZER INC. | 2 | $40 |
| Phathom Pharmaceuticals, Inc. | 2 | $31 |
Products named: REZDIFFRA, Livdelzi, IBSRELA, XIFAXAN, LINZESS, RINVOQ, Wegovy, TREMFYA.
Industry payments across FL — which companies pay providers there.
